Ethema Fair Value
GR
The fair market value of GRST stock is 0 USD. Relative to the market price of 0.0007 USD Ethema is overvalued by 43.7%
Eyestock's quantitative valuation approach is based on the method of estimating historical multipliers. To determine whether a stock is undervalued, we compare its current price to our estimated of fair value. The more undervalued a stock is, the more investment is profitable.
Fair Relative Value
Ethema Valuation
Current GRST share ticker price is 0.0007 USD.
Price chart is not available
Current market price
Market price:
GRST stock is overvalued
It means the current price may concern as a Risky Entry Point
Ethema Health Corp Stock Valuation Calculator
How do we value a stock?
As fair value, we use the product of the median Price-to-earnings ratios at the end of each reporting period for the last 5 years and earnings per share for the last 12 months. By analogy with the fair value, we calculate the maximum and minimum ones using the corresponding P/E extremums.
1
Maximum P/E over 5 years
11.19
2
Median P/E over 5 years
1.56
3
Minimum P/E over 5 years
0.76
4
Earning per share (last 12 months)
0 USD
Maximum value
1
x
4
=
0 USD
Fair value
2
x
4
=
0 USD
Minimum value
3
x
4
=
0 USD
Ethema Health Corp price metrics
-51.52
Annual return (geometric mean)
257.51
Risk (standard deviation) of returns
β
2.35
Beta (volatility compared to market)